The latest advancement in
controlled release for liquids

Our strong commitment to R&D has yielded numerous innovations

Abuse deterrence technology for widely
used controlled substances and opiates

		Tris Pharma Announces Appointment of Dr. Mahdi Fawzi as Top R&D Executive (January, 2012)
		Tris Pharma Announces US Patent Grant Covering Platform Technology (January, 2012)
		Tris Pharma Expands Leadership Team, Adds Senior Managers in Quality and Finance (August, 2011)
		Tris Pharma Appoints Vice President of Human Resources (June, 2011)
		Tris Pharma Announces Availability of the MyKidz® Iron Product Line - the Best Tasting Iron Supplements (March, 2011)
		View more news...